Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Avobenzone "broad spectrum" sunscreens require UVA/UVB testing -- FDA proposal.

This article was originally published in The Tan Sheet

Executive Summary

AVOBENZONE "BROAD SPECTRUM" SUNSCREENS TO REQUIRE UVA/UVB TESTING prior to marketing, FDA stated in a Sept. 16 proposed rule amending the sunscreen tentative final monograph. The proposal would allow the marketing of "broad spectrum" sunscreen products containing avobenzone alone and in combination with some Category I sunscreen ingredients as long as the products are first tested for their protection against both UVA and UVB rays.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086027

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel